Targeting IgA Nephropathy

Targeting IgA Nephropathy

Update: 2025-11-03
Share

Description

Rachel Benton is a loving mother to an adorable 2-year-old boy named Stetson. Stetson doesn’t know it, but he may have already saved his mom’s life. A routine medical checkup, that Rachel only had because she was pregnant, showed protein in her urine. That discovery led to a biopsy and ultimately a diagnosis of IgA nephropathy – a serious kidney disease.

With patients like Rachel in mind, the research team at Vertex Pharmaceuticals is working on new approaches to address IgA nephropathy.

Produced by Bloomberg Media Studios and Vertex Pharmaceuticals.

-----------------------

Featured guests:

Rachel Benton is a young mother who lives with IgA nephropathy.

Dr. Jonathan Barratt leads the Renal Research Group within the College of Life Sciences, University of Leicester.

Mark Bunnage is Senior Vice President and Head of Global Research at Vertex Pharmaceuticals.

Dr Manish Maski is a board-certified nephrologist and helps lead Vertex’s research into IgA nephropathy in Boston.

Read more about Vertex's commitment to targeting kidney disease

Comments 
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Targeting IgA Nephropathy

Targeting IgA Nephropathy

Jordan Gass Poore, Rachel Benton, Dr Jonathan Barratt, Mark Bunnage, Dr Manish Maski